Tehran University of Medical Sciences

Science Communicator Platform

Share By
Serological Tests for Covid-19: Potential Opportunities Publisher Pubmed



Tantuoyir MM1, 2, 3 ; Rezaei N1, 4, 5
Authors

Source: Cell Biology International Published:2021


Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel betacoronavirus, caused a pandemic leading to a standstill of nearly all global activities. There are some controversies on the production of specific immunoglobulin M (IgM) and IgG antibodies after the infection with SARS-CoV-2. This paper seeks to elaborate on the potential application of IgM and IgG antibodies and the viral antigens for the diagnosis and the course of the disease as well as the recurrence of positive nucleic acid tests after discharge. © 2020 International Federation for Cell Biology
Related Docs
View other Related Docs
1. Covid-19: A Trigger of Autoimmune Diseases, Cell Biology International (2023)
2. Covid-19: From the Molecular Mechanisms to Treatment, Tanaffos (2022)
3. A Review on the Mechanisms Involved in the Immunopathogenesis of Sars-Cov-2, Journal of Military Medicine (2020)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (2)
Ahmad Nejati (1)
Other Related Docs
4. Investigation of Durability of Sars-Cov-2-Specific Igg and Igm Antibodies in Recovered Covid-19 Patients: A Prospective Study, Avicenna Journal of Medical Biotechnology (2022)
5. Classification of Viral Proteins Expressed by the Sars-Cov-2 Genome, Acta Microbiologica Hellenica (2022)
6. Spatial Transcriptomics and Single Cell-Rnaseq Reveals Cellular Heterogeneity of Sars-Cov-2 in Lung Tissues and Global Mutational Patterns in Covid-19 Patients, Journal of Medical Virology (2025)
7. Future Developments in Biosensors for Field-Ready Sars-Cov-2 Virus Diagnostics, Biotechnology and Applied Biochemistry (2021)
8. Novel and Emerging Mutations of Sars-Cov-2: Biomedical Implications, Biomedicine and Pharmacotherapy (2021)
9. Improvement of the Inactivated Sars-Cov-2 Vaccine Potency Through Formulation in Alum/Naloxone Adjuvant; Robust T Cell and Anti-Rbd Igg Responses, Iranian Journal of Basic Medical Sciences (2022)
10. Sars-Cov-2 Intrahost Evolution in Immunocompromised Patients in Comparison With Immunocompetent Populations After Treatment, Journal of Medical Virology (2023)
11. Epitope Mapping of Neutralising Anti-Sars-Cov-2 Monoclonal Antibodies: Implications for Immunotherapy and Vaccine Design, Reviews in Medical Virology (2022)
12. Efficacy of Mrna, Adenoviral Vector, and Perfusion Protein Covid-19 Vaccines, Biomedicine and Pharmacotherapy (2022)
13. Sars-Cov-2–A Tough Opponent for the Immune System, Archives of Medical Research (2020)
14. The Role of Mesenchymal Stromal Cells in Immune Modulation of Covid-19: Focus on Cytokine Storm, Stem Cell Research and Therapy (2020)
15. Immunopathological Similarities Between Covid-19 and Influenza: Investigating the Consequences of Co-Infection, Microbial Pathogenesis (2021)
16. Immune Mechanisms in the Pathogenesis of Coronavirus Disease 2019, Journal of Cellular and Molecular Anesthesia (2022)
17. Development of a Multiepitope Vaccine Against Sars-Cov-2: Immunoinformatics Study, JMIR Bioinformatics and Biotechnology (2022)
18. Ascorbic Acid and Α-Tocopherol in the Inactivated Sars-Cov-2 Vaccine Formulation: Induction of the Th1 Pattern in Aged Mice, Viral Immunology (2024)
19. A Review of Covid-19 Vaccines and Major Considerations for Diabetic Patients, Biotechnology and Applied Biochemistry (2022)
20. A Novel Coronavirus Disease (Covid-19): A Review of Host Cell Signaling Pathways, Tanaffos (2020)